Glioblastoma (GBM) is the most common primary malignant type of brain neoplasm in adults
and carries a dismal prognosis. The current standard of care for GBM is surgical excision …

Background Immune checkpoint inhibition (ICI) with anti-CTLA-4 and/or anti-PD-1
antibodies is standard treatment for metastatic melanoma. Anti-PD-1 (pembrolizumab …

Radionecrosis is a well-characterized effect of stereotactic radiosurgery (SRS) and is
occasionally associated with serious neurologic sequelae. Here, we investigated the …

Purpose This meta-analysis examined roles of several metabolites in differentiating
recurrent tumor from necrosis in patients with brain tumors using MR perfusion and …

Purpose: To evaluate the diagnostic accuracy of PET with different radiotracers and
parameters in differentiating between true glioma progression (TPR) and post treatment …

Posttreatment high-grade gliomas are usually monitored with contrast-enhanced MRI, but its
diagnostic accuracy is limited as it cannot adequately distinguish between true tumor …

Introduction Radiological assessment of brain tumors is widely based on the Radiology
Assessment of Neuro-Oncology (RANO) criteria that consider non-specific T1 and T2 …

A previous review published in 2012 demonstrated the role of clinical PET for diagnosis and
management of brain tumors using mainly FDG, amino acid tracers, and 18 F …

Several new tracers are being developed for use with PET to assess pathways that are
altered in cancers, including energy use, cellular signaling, transport, and proliferation …

Opinion statement Intracranial stereotactic radiosurgery (SRS) is an effective and convenient
treatment for many brain conditions. Data regarding safety come mostly from retrospective …